Celldex Therapeutics (NASDAQ:CLDX): Q4 EPS of -$0.27 misses by $0.02. Revenue of $3.65M beats by $1.2M. (PR)
Celldex Therapeutics (NASDAQ:CLDX): Q4 EPS of -$0.27 misses by $0.02. Revenue of $3.65M beats by...
Recommended For You
More Trending News
About CLDX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| CLDX | - | - |
| Celldex Therapeutics, Inc. | ||